AKT serine/threonine kinase 3
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The AKT3 gene provides instructions for making a protein that is most active in the nervous system. The AKT3 protein is a key regulator of a chemical signaling pathway called the PI3K-AKT-mTOR pathway. This signaling influences many critical cell functions, including the creation (synthesis) of new proteins, cell growth and division (proliferation), and the survival of cells. The PI3K-AKT-mTOR pathway is essential for the normal development of many parts of the body, including the brain. Studies suggest that the AKT3 protein plays a critical role in determining brain size.
Video picks for GenesVideo library
Normal function
The AKT3 gene provides instructions for making a protein that is most active in the nervous system. The AKT3 protein is a key regulator of a chemical signaling pathway called the PI3K-AKT-mTOR pathway. This signaling influences many critical cell functions, including the creation (synthesis) of new proteins, cell growth and division (proliferation), and the survival of cells. The PI3K-AKT-mTOR pathway is essential for the normal development of many parts of the body, including the brain. Studies suggest that the AKT3 protein plays a critical role in determining brain size.
Conditions referring to this gene or chromosome
Other names
PKB gamma
PKB-GAMMA
PKBG
PRKBG
RAC-gamma
RAC-gamma serine/threonine protein kinase
RAC-PK-gamma
STK-2
v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma)
Patient picks for Genes

Mental health
Eat Your Way to Calm - Foods That Fight Stress and Anxiety
Discover how incorporating magnesium-rich greens, zinc-packed foods, vitamin C sources, omega-3 fatty acids, fiber, and probiotics into your diet can support mental wellbeing and help manage stress and anxiety.

Pelvic pain Q&A
How do you diagnose pelvic pain?
Dr Sarah Jarvis MBE Your doctor will ask you some questions and may examine you. Based on what they find, they may advise you to have some further investigations. [https://patient.info/health/pelvic-pain-in-women#nav-3](https://patient.info/health/pelvic-pain-in-women#nav-3)
by Dr Sarah Jarvis

Pain
How does back pain occur?
Dr Sarah Jarvis MBE This depends on what is thought to be the cause of your back pain. Your doctor will usually be able to tell what the likeliest cause is of your pain, simply by talking to you and examining you. If you haven't had your back pain for very long and your doctor doesn't think it is serious, you are unlikely to need any tests. [https://patient.info/health/back-and-spine-pain#nav-3](https://patient.info/health/back-and-spine-pain#nav-3)
by Dr Sarah Jarvis

Vulvar itch
How to stop vulvar itch?
Dr Sarah Jarvis MBE Infections are caused by germs such as bacteria, viruses and fungi. Infections in the vagina are common and these infections can also affect your vulva. [https://patient.info/health/vulval-problems-leaflet#nav-3](https://patient.info/health/vulval-problems-leaflet#nav-3)
by Dr Sarah Jarvis

Fibroids Q&A
Do fibroids bleed?
Dr Sarah Jarvis MBE Fibroids are common and usually cause no symptoms. However, they can sometimes cause heavy periods, tummy (abdominal) swelling and urinary problems. [https://patient.info/health/periods-and-period-problems/fibroids#nav-3](https://patient.info/health/periods-and-period-problems/fibroids#nav-3)
by Dr Sarah Jarvis

Contraceptive pills and patches
How effective is the birth control patch?
Dr Rosemary Leonard The patch sticks to the skin. If used correctly, it is a very effective form of contraception. Between 3-90 women in 1,000 using the contraceptive patch will become pregnant each year. It is about as effective as the COC pill. For more information on the contraceptive patch, go to [https://patient.info/health/hormone-pills-patches-and-rings/contraceptive-patch](https://patient.info/health/hormone-pills-patches-and-rings/contraceptive-patch)
by Dr Rosemary Leonard MBE, MRCGP
Related patient information and medicines

Patient information leaflet
Glycogen storage disorders
Glycogen storage disorders are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. They mostly tend to affect your liver and muscles. Most are diagnosed in childhood. Symptoms include weakness,.

Patient information leaflet
Primary liver cancer
Primary liver cancer is uncommon in the UK but is common in other parts of the world. In the UK, most cases develop as a complication of scarring of the liver (cirrhosis). In general the outlook is poor. There are new medicines being developed for the treatment of liver cancer. For example, sorafenib is a type of medicine called a multi-targeted.

Patient information leaflet
Muscular dystrophy
Also, if a child has delayed motor milestones (as mentioned above), a doctor may advise testing for MD, even though the problem could be due to another cause. MD may be diagnosed using one or more of the following tests: A blood test Blood tests for creatine kinase (CK) - in many types of MD, the blood level of CK is very high. A muscle biopsy.

Patient information leaflet
Mouth cancer
Diagnosing mouth cancer Your healthcare professional may suspect mouth cancer if you have a lesion in your mouth (such as a sore, an ulcer or a lump) which has not healed for 3 wee... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or.

Patient information leaflet
Juvenile idiopathic arthritis
As they are relatively new medicines, there are still studies being done to establish whether there are any long-term health risks from taking them. Options include: Etanercept Etanercept Tocilizumab Infliximab Abatacept Adalimumab Tofacitinib is another new drug. It belongs to a type of drug called JAK kinase inhibitors. It is sometimes used if.

Patient information leaflet
Pompholyx
Its effectiveness for pompholyx is still being stud... Dapilumab : this medication is used for a type of eczema called atopic dermatitis. In some cases it has been shown to be helpful for the treatment of pompholyx. Janus Kinase (JAK) inhibitors : these medications, available as creams or pills, target specific pathways involved in inflammation..
Further reading and references
- AKT serine/threonine kinase 3; MedlinePlus, National Library of Medicine.
- Ballif BC, Rosenfeld JA, Traylor R, Theisen A, Bader PI, Ladda RL, Sell SL, Steinraths M, Surti U, McGuire M, Williams S, Farrell SA, Filiano J, Schnur RE, Coffey LB, Tervo RC, Stroud T, Marble M, Netzloff M, Hanson K, Aylsworth AS, Bamforth JS, Babu D, Niyazov DM, Ravnan JB, Schultz RA, Lamb AN, Torchia BS, Bejjani BA, Shaffer LG. High-resolution array CGH defines critical regions and candidate genes for microcephaly, abnormalities of the corpus callosum, and seizure phenotypes in patients with microdeletions of 1q43q44. Hum Genet. 2012 Jan;131(1):145-56. doi: 10.1007/s00439-011-1073-y. Epub 2011 Jul 29.
- Cohen MM Jr. The AKT genes and their roles in various disorders. Am J Med Genet A. 2013 Dec;161A(12):2931-7. doi: 10.1002/ajmg.a.36101. Epub 2013 Sep 3.
- Lee JH, Huynh M, Silhavy JL, Kim S, Dixon-Salazar T, Heiberg A, Scott E, Bafna V, Hill KJ, Collazo A, Funari V, Russ C, Gabriel SB, Mathern GW, Gleeson JG. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet. 2012 Jun 24;44(8):941-5. doi: 10.1038/ng.2329.
- Mirzaa G. MPPH Syndrome. 2016 Nov 17 [updated 2022 Jul 28]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK396098/
- Mirzaa GM, Riviere JB, Dobyns WB. Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Genet C Semin Med Genet. 2013 May;163C(2):122-30. doi: 10.1002/ajmg.c.31361. Epub 2013 Apr 16.
- Nakamura K, Kato M, Tohyama J, Shiohama T, Hayasaka K, Nishiyama K, Kodera H, Nakashima M, Tsurusaki Y, Miyake N, Matsumoto N, Saitsu H. AKT3 and PIK3R2 mutations in two patients with megalencephaly-related syndromes: MCAP and MPPH. Clin Genet. 2014 Apr;85(4):396-8. doi: 10.1111/cge.12188. Epub 2013 Jun 10. No abstract available.
- Nellist M, Schot R, Hoogeveen-Westerveld M, Neuteboom RF, van der Louw EJ, Lequin MH, Bindels-de Heus K, Sibbles BJ, de Coo R, Brooks A, Mancini GM. Germline activating AKT3 mutation associated with megalencephaly, polymicrogyria, epilepsy and hypoglycemia. Mol Genet Metab. 2015 Mar;114(3):467-73. doi: 10.1016/j.ymgme.2014.11.018. Epub 2014 Dec 5.
- Poduri A, Evrony GD, Cai X, Elhosary PC, Beroukhim R, Lehtinen MK, Hills LB, Heinzen EL, Hill A, Hill RS, Barry BJ, Bourgeois BF, Riviello JJ, Barkovich AJ, Black PM, Ligon KL, Walsh CA. Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron. 2012 Apr 12;74(1):41-8. doi: 10.1016/j.neuron.2012.03.010.
- Riviere JB, Mirzaa GM, O'Roak BJ, Beddaoui M, Alcantara D, Conway RL, St-Onge J, Schwartzentruber JA, Gripp KW, Nikkel SM, Worthylake T, Sullivan CT, Ward TR, Butler HE, Kramer NA, Albrecht B, Armour CM, Armstrong L, Caluseriu O, Cytrynbaum C, Drolet BA, Innes AM, Lauzon JL, Lin AE, Mancini GM, Meschino WS, Reggin JD, Saggar AK, Lerman-Sagie T, Uyanik G, Weksberg R, Zirn B, Beaulieu CL; Finding of Rare Disease Genes (FORGE) Canada Consortium; Majewski J, Bulman DE, O'Driscoll M, Shendure J, Graham JM Jr, Boycott KM, Dobyns WB. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet. 2012 Jun 24;44(8):934-40. doi: 10.1038/ng.2331.
- Wang D, Zeesman S, Tarnopolsky MA, Nowaczyk MJ. Duplication of AKT3 as a cause of macrocephaly in duplication 1q43q44. Am J Med Genet A. 2013 Aug;161A(8):2016-9. doi: 10.1002/ajmg.a.35999. Epub 2013 Jun 21.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

